Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Comparative, Open-labelled, Randomised, Clinical Study to Assess a Fixed Dose of Oral Pyronaridine Artesunate Granule Formulation vs. Coartem® Crushed Tablets in Infants With Acute Uncomplicated Plasmodium Falciparum Malaria

NCT00541385 is registered in ClinicalTrials.gov with Medicines for Malaria Venture as lead sponsor.

NCT NCT00541385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00541385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Comparative, Open-labelled, Randomised, Clinical Study to Assess a Fixed Dose of Oral Pyronaridine Artesunate Granule Formulation vs. Coartem® Crushed Tablets in Infants With Acute Uncomplicated Plasmodium Falciparum Malaria
Lead sponsor
Medicines for Malaria Venture
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2007
Completion date
November 30, 2008
Enrollment
535 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

malaria